Study Shows Minocycline Did Not Slow Vision Loss in Dry AMD

A recent clinical study at the National Eye Institute (NEI) has shown that the antibiotic minocycline did not slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD). The study aimed to test whether inhibiting microglia with minocycline might help slow geographic atrophy expansion and its corresponding vision loss, but found no difference in geographic atrophy expansion rate or vision loss with minocycline. This study provides valuable insights into potential treatments for dry AMD and the role of inflammation in the progression of the disease.